Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer
Clinical trial NCT06437353 · RECRUITING
Trial details
- NCT number
- NCT06437353
- Sponsor
- Anhui Provincial Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-25
- Primary completion
- 2025-10-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.